Form 4: Edwards Lifesciences Director Leslie Stone Heisz Reports Acquisition of Restricted Stock Units

Director Leslie Stone Heisz reports acquisition of 3,528 restricted stock units in Edwards Lifesciences Corp.

Summary

• On May 9, 2025, Leslie Stone Heisz, a director of Edwards Lifesciences Corp, acquired 3,528 shares of common stock in the form of restricted stock units.
• The restricted stock units were granted under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
• These units are scheduled to vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• Following the transaction, Heisz directly owns 33,563 shares of Edwards Lifesciences Corp common stock.

Sentiment

Score: 5

Explanation: This is a neutral filing, simply reporting a transaction. It doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.

Future Outlook

The restricted stock units will vest 100% after one year from the grant date or at the next annual meeting of stockholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Form 4, beneficial ownership, restricted stock units, director, Edwards Lifesciences, Heisz